Cargando…
Efficacy of Serotonin and Dopamine Activity Modulators in the Treatment of Negative Symptoms in Schizophrenia: A Rapid Review
Schizophrenia is among the fifteen most disabling diseases worldwide. Negative symptoms (NS) are highly prevalent in schizophrenia, negatively affect the functional outcome of the disorder, and their treatment is difficult and rarely specifically investigated. Serotonin-dopamine activity modulators...
Autores principales: | Brasso, Claudio, Colli, Gianluca, Sgro, Rodolfo, Bellino, Silvio, Bozzatello, Paola, Montemagni, Cristiana, Villari, Vincenzo, Rocca, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046337/ https://www.ncbi.nlm.nih.gov/pubmed/36979900 http://dx.doi.org/10.3390/biomedicines11030921 |
Ejemplares similares
-
Second Generation Long-Acting Injectable Antipsychotics in Schizophrenia: The Patient’s Subjective Quality of Life, Well-Being, and Satisfaction
por: Brasso, Claudio, et al.
Publicado: (2023) -
Role of 3-monthly long-acting injectable paliperidone in the maintenance of schizophrenia
por: Brasso, Claudio, et al.
Publicado: (2017) -
The relative contributions of insight and neurocognition to intrinsic motivation in schizophrenia
por: Brasso, Claudio, et al.
Publicado: (2022) -
Primary Psychosis: Risk and Protective Factors and Early Detection of the Onset
por: Brasso, Claudio, et al.
Publicado: (2021) -
Models Predicting Psychosis in Patients With High Clinical Risk: A Systematic Review
por: Montemagni, Cristiana, et al.
Publicado: (2020)